Bustamante, Regine Fher S.
HRN: 21-22-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2024
CEFUROXIME 750MG (VIAL)
04/08/2024
04/14/2024
IVTT
310mg
Q8h
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes